Trading in Genzyme (GENZ) provided for some read as to how the market weighs current EPS vs. potential future profits. GENZ's solid third quarter results and a boost in revenue projections for its Renagel phosphate...

GeneFormatics (San Diego, Calif.), which is using in silico technologies to analyze human protein sequences and pathogen proteomes, raised $22 million in a private financing. Investors included Bruker AXS; Bruker BioSpin; Bruker Daltonics (BDAL); TaKaRa...

Proteomics play GeneFormatics (San Diego, Calif.) raised $15 million in a private round. Investors included Perseus-Soros BioPharmaceutical Fund; Merrill Lynch Ventures; OrbiMed Advisors; GeneChem Management; Burrill & Co.; Inglewood Ventures; and Moss Forest Venture. BC...